SCHEMBL882263

SCHEMBL882263

C=C(OC)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18629124 0.80
SCHEMBL18863926 0.76
SCHEMBL78483 0.74
SCHEMBL18373286 0.73
SCHEMBL16374077 0.73
SCHEMBL16374083 0.73
SCHEMBL10042025 0.73
SCHEMBL11300053 0.73
SCHEMBL13190649 0.73
SCHEMBL22745225 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239828-A1 MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2024-07-18 US disclosed
US-20240072809-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2024-02-29 US disclosed
US-11819551-B2 ASGPR-binding compounds for the degradation of extracellular proteins AVILAR THERAPEUTICS, INC. (US) 2023-11-21 US disclosed
US-20230322996-A1 POLYMER-INTERACTION MOLECULE CONJUGATES AND METHODS OF USE LIFE TECHNOLOGIES AS (NO) 2023-10-12 US disclosed
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins UNIV YALE (US) 2023-07-27 US disclosed
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2018-05-17 US disclosed
US-20180065960-A1 QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS PRINCIPIA BIOPHARMA INC. 2018-03-08 US disclosed
US-9815834-B2 Quinolone derivatives as fibroblast growth factor receptor inhibitors PRINCIPIA BIOPHARMA, INC. (US) 2017-11-14 US disclosed
US-9567334-B2 Quinolone derivatives as fibroblast growth factor receptor inhibitors PRINCIPIA BIOPHARMA, INC. (US) 2017-02-14 US disclosed
WO-2016172631-A2 SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-10-27 WO disclosed
EP-0494906-A1 METHOD FOR CONTINUOUS PRODUCTION OF $g(D)1-ENOL ETHERS HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-22 EP disclosed
US-5103017-A PYRAZOLINES AND THEIR USE AS SAFENERS HOECHST AKTIENGESELLSCHAFT (DE) 1992-04-07 US disclosed
EP-0439835-A2 Process for the preparation of pyrazolecarboxylic acid derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1991-08-07 EP disclosed
US-5037468-A Prevent phytotoxic damage by herbicides HOECHST AKTIENGESELLSCHAFT (DE) 1991-08-06 US disclosed
US-5013444-A Process for separating off enol ethers from reaction mixtures containing alcohols HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-07 US disclosed
WO-1991004956-A1 METHOD FOR CONTINUOUS PRODUCTION OF Δ1-ENOL ETHERS HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-18 WO disclosed
EP-0415334-A1 Process for separation of enol ethers from mixtures thereof with alcohols HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-06 EP disclosed
US-4990602-A Bactericides TAISHO PHARMACEUTICAL CO., LTD. (JP) 1991-02-05 US disclosed
EP-0409118-A1 Pyrazolines and their use as antidotes Hoechst Schering AgrEvo GmbH (DE) 1991-01-23 EP disclosed
EP-0272110-A2 Erythromycin a derivatives and method for the preparation of the same TAISHO PHARMACEUTICAL CO. LTD (JP) 1988-06-22 EP disclosed